Ohcanbohtosat - Cleton-Jansen, A-M
- Čájehuvvo 1 - 19 / 19
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts) Dahkki Langezaal, S M, Graadt van Roggen, J F, Cleton-Jansen, A M, Baelde, J J, Hogendoorn, P C W
Almmustuhtton 2001Teaksta -
8
-
9
Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type Dahkki Vos, C B J, Haar, N T ter, Rosenberg, C, Peterse, J L, Cleton-Jansen, A-M, Cornelisse, C J, Vijver, M J van de
Almmustuhtton 1999Teaksta -
10
EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Dahkki Bovée, J V, Cleton-Jansen, A M, Wuyts, W, Caethoven, G, Taminiau, A H, Bakker, E, Van Hul, W, Cornelisse, C J, Hogendoorn, P C
Almmustuhtton 1999Teaksta -
11
Loss of heterozygosity on chromosome arm 16q in breast cancer: clinical, molecular and statistical approaches Dahkki Cleton-Jansen, A-M, van Beerendonk, HM, ter Haar, NT, Eilers, PHC, van Houwelingen, HC, Bonsing, BA, Smit, VTHBM, van Ommen, G-JB, Cornelisse, CJ
Almmustuhtton 2000Teaksta -
12
Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways Dahkki Cleton-Jansen, A-M, Anninga, J K, Briaire-de Bruijn, I H, Romeo, S, Oosting, J, Egeler, R M, Gelderblom, H, Taminiau, A H M, Hogendoorn, P C W
Almmustuhtton 2009Teaksta -
13
Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways Dahkki Cleton-Jansen, A-M, Anninga, J K, Briaire-de Bruijn, I H, Romeo, S, Oosting, J, Egeler, R M, Gelderblom, H, Taminiau, A H M, Hogendoorn, P C W
Almmustuhtton 2009Teaksta -
14
E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Dahkki Vos, C. B., Cleton-Jansen, A. M., Berx, G., de Leeuw, W. J., ter Haar, N. T., van Roy, F., Cornelisse, C. J., Peterse, J. L., van de Vijver, M. J.
Almmustuhtton 1997Teaksta -
15
Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3 Dahkki Cleton-Jansen, A-M, Moerland, E W, Pronk, J C, van Berkel, C G M, Apostolou, S, Crawford, J, Savoia, A, Auerbach, A D, Mathew, C G, Callen, D F, Cornelisse, C J
Almmustuhtton 1999Teaksta -
16
E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines Dahkki Lombaerts, M, van Wezel, T, Philippo, K, Dierssen, J W F, Zimmerman, R M E, Oosting, J, van Eijk, R, Eilers, P H, van de Water, B, Cornelisse, C J, Cleton-Jansen, A-M
Almmustuhtton 2006Teaksta -
17
Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery Dahkki PosthumaDeBoer, J, Piersma, S R, Pham, T V, van Egmond, P W, Knol, J C, Cleton-Jansen, A M, van Geer, M A, van Beusechem, V W, Kaspers, G J L, van Royen, B J, Jiménez, C R, Helder, M N
Almmustuhtton 2013Teaksta -
18
Targeting survivin as a potential new treatment for chondrosarcoma of bone Dahkki de Jong, Y, van Oosterwijk, J G, Kruisselbrink, A B, Briaire-de Bruijn, I H, Agrogiannis, G, Baranski, Z, Cleven, A H G, Cleton-Jansen, A-M, van de Water, B, Danen, E H J, Bovée, J V M G
Almmustuhtton 2016Teaksta -
19
European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables Dahkki Launonen, V, Laake, K, Huusko, P, Niederacher, D, Beckmann, M W, Barkardottir, R B, Geirsdottir, E K, Gudmundsson, J, Rio, P, Bignon, Y-J, Seitz, S, Scherneck, S, Bièche, I, Champème, M-H, Birnbaum, D, White, G, Varley, J, Sztán, M, Olah, E, Osorio, A, Benitez, J, Spurr, N, Velikonja, N, Peterlin, B, Borg, Å, Cleton-Jansen, A-M, Devilee, P, Bloigu, R, Lidereau, R, Børresen-Dale, A-L, Winqvist, R
Almmustuhtton 1999Teaksta